Low avidity of human serum antibodies for Borna disease virus antigens questions their diagnostic value

Molecular Psychiatry
U AllmangP Staeheli

Abstract

Borna disease virus (BDV) can induce neurological disease in animals. Since viral nucleic acid, infectious particles and antibodies recognizing BDV antigens were found at higher frequencies in psychiatric patients than in healthy controls, BDV is suspected to cause psychiatric disorders in humans. However, the human origin of these viruses has recently been questioned. To diagnose BDV infections, sera are usually analyzed for antiviral antibodies by indirect immunofluorescence (IFA) on virus-infected cells. This study reveals that the reactive antibodies in human sera mainly recognized the BDV phosphoprotein, whereas animal sera preferentially detected the viral nucleoprotein. Immunoglobulin (Ig) G in sera of experimentally or naturally infected animals bound to the viral antigen with high avidity, ie resisting 3 M urea, whereas reactive IgG in human sera did not. Longitudinal studies showed that reactive human antibodies persisted for many years without gaining high avidity for BDV antigens, indicating that they were probably not induced by BDV but rather by infection with an antigenically related microorganism of unknown identity or by exposure to other related immunogens.

References

Dec 15, 1988·International Journal of Cancer. Journal International Du Cancer·J SchüpbachZ Tomasik
Jan 1, 1980·Medical Microbiology and Immunology·S Herzog, R Rott
Feb 28, 1997·Schizophrenia Research·R W WaltripK M Carbone
May 16, 1998·The Journal of Biological Chemistry·M SchwemmleW I Lipkin
Apr 25, 2000·Journal of Virology·Y NakamuraK Ikuta
May 24, 2000·Journal of Virology·N NowotnyM Schwemmle
Aug 22, 2000·The Journal of General Virology·P StaeheliM Schwemmle

❮ Previous
Next ❯

Citations

May 30, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·K Lieb, P Staeheli
Apr 23, 2010·Psychiatry and Clinical Neurosciences·Alexander Heinrich, Michael Adamaszek
Jul 15, 2003·Clinical Microbiology Reviews·Liv Bode, Hans Ludwig
Dec 10, 2003·Journal of Clinical Microbiology·Emmanuelle CottoMarie-Edith Lafon
Mar 12, 2010·Journal of Virology·Peter StaeheliBernd Kaspers
Mar 2, 2002·The Lancet Infectious Diseases·M Schwemmle
Sep 13, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Hidenori MatsunagaMasatoshi Takeda
Feb 25, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·M J HoferA Pagenstecher
Jun 14, 2002·Biological Psychiatry·Christian BillichMartin Schwemmle
Dec 12, 2012·The Journal of General Virology·Paula M KinnunenOlli Vapalahti
Feb 20, 2008·Neuropathology and Applied Neurobiology·N Werner-KeissC Herden
Jan 1, 2012·Uirusu·Keizo Tomonaga
Jul 9, 2009·Indian Journal of Medical Microbiology·R ThakurB Sharma
Jan 12, 2020·The Lancet Infectious Diseases·Tomoyuki Honda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.